Seven-Country Market for Therapies to Treat Erectile Dysfunction Will Approach $4 Billion by 2008, Reports Decision Resources, Inc.
April 27, 1999
WALTHAM, Mass., April 26 /PRNewswire/ via NewsEdge Corporation -- In 1998, erectile dysfunction (ED) affected more than 75 million men in the world's seven major pharmaceutical markets (the United States, France, Germany, Italy, Spain, the United Kingdom, and Japan), and prevalence is expected to exceed 90 million in 2008. The 1998 approval of Pfizer's Viagra, the first oral therapy approved for the treatment of ED, has revolutionized the ED treatment market by stimulating a dramatic rise in both the diagnosed and drug-treated populations of ED sufferers. Viagra also catapulted sales of erectile dysfunction therapies into the stratosphere, more than quadrupling the size of the ED market in just one year. Although Viagra addresses nearly all of the needs of the ED patient population, opportunity does exist for new, fast-acting, oral pharmacotherapies with greater specificity and minimal side effects.
|
